Google-backed medical research company Calico will partner with Ancestry.com to identify genetic patterns of anonymous people who have lived long lives with the aim of producing drugs to encourage those traits.
Calico and Ancestry.com’s subsidiary, AncestryDNA, will study the “anonymized data from millions of public family trees and a growing database of over one million genetic samples” in “an effort to investigate human heredity of lifespan,” Calico announced last week.
Once AncestryDNA and Calico determine how genetics have helped some live exceptionally long, Calico will then work to “develop and commercialize any potential therapeutics that emerge from the analysis,” the company said.
AncestryDNA has genotyped DNA sequences of more than one million of Ancestry.com’s customers, according to Re/code, and has around two million active subscribers. Ancestry.com CEO Tim Sullivan said that many medical research companies have long requested access to Ancestry.com’s trove of data.
Read full report via RT.